Editorial Ombitasvir/paritaprevir/ritonavir plus weight based ribavirin versus ledipasvir/sofosbuvir fixed dose combination in treatment of HCV genotype IV in a patient with idiopathic pulmonary hypertension and renal impairment Author(s): Marwa Ibrahim Mohamed Abd El Rahman*
Journal of Hepato-Gastroenterology received 38 citations as per Google Scholar report